NL-OMON33980已完成不适用
Effects of INsulin dEtemiR and neutral protaminE hagedorn (nph) insulin on BRain glucOse metabolism: a study in persons with type 1 diabetes - Insulin detemir action in cerebro/ INcEREBRO
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Type 1 diabetic patients
- •Age 21-60 years
- •Diabetes duration minimal 2 years
- •HbA1c ~ 7,5%
排除标准
- •Recent onset of DM
- •BMI < 18 OR > 35 kg/m2
- •History of major heart/renal disease
- •Severe untreated proliferative retinopathy
- •History of recurrent severe hypoglycaemia
- •(History of) brain disorders
- •Alcohol abuse
- •(History of) drug abuse, benzodiazepines, selective beta-blockers, oral steoids, oral anticoagulants
- •Current psychiatric disease/treatment
- •(history of) eating disorders
- •History of severe head trauma accompanied by loss of consciousness
- •Any endocrine disease not well controlled for at least 3 months
- •Inability to undergo MRI
- •Visual acuity < 0.3
- •Known or suspected allergy to trial product or related products
研究者
相似试验
进行中（未招募）
不适用
Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP AxisPatients with type 1 diabetesMedDRA version: 14.1Level: LLTClassification code 10012608Term: Diabetes mellitus insulin-dependentSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-002210-37-DKniversity of Aarhus
已完成
不适用
Insulin Detemir Action in CerebroType 1 DiabetesNCT00626080Amsterdam UMC, location VUmc40
进行中（未招募）
不适用
Comparison of the effect of insulin detemir and NPH insulin on dawn phenomenon in patients with Type 1 diabetes An open-labelled, randomised, cross-over, multi-center trial comparing the effect of insulin detemir versus NPH insulin as basal insulins on dawn phenomenon and the glycaemic control in patients with Type 1 diabetes treated on a basal-bolus regimen - Dawn phenomenon – insulin detemirType 1 diabetes mellitus, dawn phenomenonEUCTR2005-003877-26-HUational Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioType 2 diabetesMedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusEUCTR2007-005317-19-GBovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extension - NDEUCTR2007-005317-19-ITOVO NORDISK940